Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07135531 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring (CGM) in an Underserved Population
A NA study, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07135531 is a NA study that is actively recruiting participants, run by Tulane University. The registered enrollment target is 50 participants.
The verdict
NCT07135531, a NA study, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.
Interventions
- DEVICE Continuous Glucose Monitoring (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-03-19 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07135531
The ClinicalTrials.gov registry entry for NCT07135531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring (CGM) is the first listed.
NCT07135531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07135531 about?
NCT07135531 is a clinical study titled "Continuous Glucose Monitoring (CGM) in an Underserved Population". The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide b...
What is the current status of trial NCT07135531?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-19. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07135531?
The interventions under investigation include: Continuous Glucose Monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT07135531?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.